Terminalia Arjuna

Last Updated: May 21, 2025

Arjuna is typically made from the bark of the tree Terminalia arjuna, a large tree common throughout India. It has most often been studied for cardiovascular disease, where it has improved heart failure in some studies. Arjuna has inconsistently improved other cardiac outcomes such as blood pressure.

Terminalia Arjuna is most often used for

What is arjuna?

Arjuna, or Terminalia arjuna, is a large evergreen tree that grows abundantly throughout India. Different parts of the tree have been used traditionally for a wide variety of ailments,[1][10][11] and the bark has often been used for cardiovascular concerns.[12][11] Traditionally, an extract has been made from arjuna by heating powdered bark in alcohol, clarified butter, or milk.[13][14]

What are arjuna’s main benefits?

Most of the randomized controlled trials examining arjuna have investigated its effects on cardiovascular health or heart function. Improvements in outcomes related to heart failure were found in 4 of 5 trials.[2][9][8][15][3]

One trial found arjuna effective for skin moisturization in postmenopausal women, but conflicts of interest reduce our confidence in the results.[16]

How does arjuna work?

Arjuna contains various compounds such as flavonoids (60%–70%), tannins (20–24%), phytosterols, triterpenoids, and saponins and has shown blood-pressure-lowering, anti-inflammatory, antioxidant, anti-atherosclerotic, and cardiotonic (strengthening the heart) effects.[13][1][17][12][18][19][20][14]

In studies in cats and dogs, arjuna reduced blood pressure in a dose-dependent manner, likely by activating adrenergic beta-2 receptors (which causes blood vessels to dilate), and/or by acting directly on heart muscle cells.[21][22][14]

In rodent studies, arjuna has shown anti-inflammatory activity by inhibiting COX-2 enzymes and histamine and increasing antioxidant enzymes like glutathione S-transferase, superoxide dismutase, and catalase (which gets rid of hydrogen peroxide, a harmful byproduct of cellular metabolism).[23][24][25][26][27][12] Arjuna also inhibited lipid peroxidation and prevented the associated decrease in the levels of antioxidants such as glutathione.[28][18][19] In one study, arjuna decreased the size of atherosclerotic lesions (areas of plaque buildup), likely by decreasing cholesterol levels.[29]

In in vitro studies, arjuna extract improved the contractility and relaxation of rodent heart cells by increasing calcium levels.[30][13]

What are other names for Terminalia Arjuna?
Note that Terminalia Arjuna is also known as:
  • Indradru
  • Veeravriksha
  • Partha
  • Marudhu
  • Yella maddi
  • Arjhan
  • Sadaru
Dosage information

Formulation:

Arjuna has been given as a capsule in many studies,[1][2][3][4][5] though it has been given as a powder as well.[6]

In the studies reviewed for the writing of this page, there were no measurements of the levels of the constituents in arjuna (such as arjunic acid or others) used in the study interventions.[7]

Range of dosages studied:

0.5 grams to 10 grams per day.[5][6]

Effective dosages:

Cardiovascular disease

Adults with cardiovascular disease (e.g., heart failure, metabolic syndrome) or without health conditions: 500 mg 1 to 3 times a day for 1 to 3 months.[3][4][8][9]

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Terminalia Arjuna
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Update History
12 days ago

All new FAQs were added to this page.

major

A major update was performed to the Arjuna page, adding evidence for a mostly consistent improvement to heart failure, and revising other evidence so that the page now reflects the inconsistent evidence for improvements to blood pressure, blood lipids, and inflammatory markers. Improvements to anaerobic capacity and power output on the previous page have been changed to no effect compared to placebo.

One meta-analysis and 9 randomized controlled trials were added to this page, and 10 narrative reviews and their references were examined for the writing of this page.

"Anaerobic capacity" has been changed from "small improvement" to "no effect" "Power output" has been changed from "small improvement" to "no effect"

Written By

Reviewed By

References
  1. ^Kaur N, Shafiq N, Negi H, Pandey A, Reddy S, Kaur H, Chadha N, Malhotra STerminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis.Cardiol Res Pract.(2014)
  2. ^Girandola RN, Srivastava SEffect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial.Am J Ther.(2017 May)
  3. ^Subir K Maulik, Vinu Wilson, Sandeep Seth, Balram Bhargava, Pamila Dua, Sivasubramanian Ramakrishnan, Chandra K KatiyarClinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trialPhytomedicine.(2016 Oct 15)
  4. ^Kapoor D, Trikha D, Vijayvergiya R, Parashar KK, Kaul D, Dhawan VShort-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.J Cardiovasc Transl Res.(2015-Apr)
  5. ^Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MMEffects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adultsInt J Ayurveda Res.(2010 Jul)
  6. ^Saleem S, Ansari AH, Ansari AEffect of Arjun āl on cardiovascular risk factors - a randomized controlled clinical trial.J Complement Integr Med.(2021-May-10)
  7. ^Maulik SK, Talwar KKTherapeutic potential of Terminalia arjuna in cardiovascular disorders.Am J Cardiovasc Drugs.(2012 Jun 1)
  8. ^Dwivedi S, Aggarwal A, Agarwal MP, Rajpal SRole of Terminalia arjuna in ischaemic mitral regurgitationInt J Cardiol.(2005 Apr 28)
  9. ^Bharani A, Ganguly A, Bhargava KDSalutary effect of Terminalia Arjuna in patients with severe refractory heart failureInt J Cardiol.(1995 May)
  10. ^Kumar V, Sharma N, Saini R, Mall S, Zengin G, Sourirajan A, Khosla PK, Dev K, El-Shazly MTherapeutic potential and industrial applications of Terminalia arjuna bark.J Ethnopharmacol.(2023 Jun 28)
  11. ^R V, N A, S R, Mahendra JAntimicrobial and anti-inflammatory activity of Terminalia arjuna.Bioinformation.(2023)
  12. ^Ramesh P, Palaniappan ATerminalia arjuna, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A Review.Pharmaceuticals (Basel).(2023 Jan 13)
  13. ^Kapoor D, Vijayvergiya R, Dhawan VTerminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.J Ethnopharmacol.(2014 Sep 11)
  14. ^Shridhar Dwivedi, Deepti ChopraRevisiting Terminalia arjuna - An Ancient Cardiovascular DrugJ Tradit Complement Med.(2014 Oct)
  15. ^Bhawani et alJournal of Pharmacy Research.(May 2013)
  16. ^Farwick M, Köhler T, Schild J, Mentel M, Maczkiewitz U, Pagani V, Bonfigli A, Rigano L, Bureik D, Gauglitz GGPentacyclic triterpenes from Terminalia arjuna show multiple benefits on aged and dry skin.Skin Pharmacol Physiol.(2014)
  17. ^Kasote DM, Katyare SS, Hegde MV, Bae HSignificance of antioxidant potential of plants and its relevance to therapeutic applications.Int J Biol Sci.(2015)
  18. ^Kokkiripati PK, Kamsala RV, Bashyam L, Manthapuram N, Bitla P, Peddada V, Raghavendra AS, Tetali SDStem-bark of Terminalia arjuna attenuates human monocytic (THP-1) and aortic endothelial cell activation.J Ethnopharmacol.(2013 Mar 27)
  19. ^Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM, Puvanakrishnan RExperimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status.Mol Cell Biochem.(2001 Aug)
  20. ^Amalraj A, Gopi SMedicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.J Tradit Complement Med.(2017 Jan)
  21. ^Nammi S, Gudavalli R, Babu BS, Lodagala DS, Boini KMPossible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs.BMC Complement Altern Med.(2003 Oct 16)
  22. ^Singh N, Kapur KK, Singh SP, Shanker K, Sinha JN, Kohli RPMechanism of cardiovascular action of Terminalia arjuna.Planta Med.(1982 Jun)
  23. ^Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SNCardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury.Life Sci.(2003 Oct 10)
  24. ^Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SKEffect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart.J Ethnopharmacol.(2001 May)
  25. ^Khaliq F, Parveen A, Singh S, Gondal R, Hussain ME, Fahim MImprovement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms.J Cardiovasc Pharmacol Ther.(2013 Sep)
  26. ^Halder S, Bharal N, Mediratta PK, Kaur I, Sharma KKAnti-inflammatory, immunomodulatory and antinociceptive activity of Terminalia arjuna Roxb bark powder in mice and rats.Indian J Exp Biol.(2009 Jul)
  27. ^Sinha M, Manna P, Sil PCTerminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress.J Med Food.(2008 Dec)
  28. ^Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim MMechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats.Cardiovasc Toxicol.(2011 Mar)
  29. ^Bhat OM, Kumar PU, Rao KR, Ahmad A, Dhawan VTerminalia arjuna prevents Interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ-mediated pathway in Apo E-/- mice.Inflammopharmacology.(2018 Apr)
  30. ^Oberoi L, Akiyama T, Lee KH, Liu SJThe aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes.Phytomedicine.(2011 Feb 15)
  31. ^Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PGEfficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.Indian Heart J.(2002)
  32. ^Kumar PU, Adhikari P, Pereira P, Bhat PSafety and efficacy of Hartone in stable angina pectoris--an open comparative trial.J Assoc Physicians India.(1999 Jul)
  33. ^Pratap Shankar KM, Ashwathykutty VEffectiveness of herbal drug Terminalia Arjuna in chronic venous insufficiency - A prospective observational study.J Vasc Nurs.(2024 Mar)
  34. ^Malik N, Dhawan V, Bahl A, Kaul DInhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease.Platelets.(2009 May)
  35. ^Priya, N. et alEffect of Terminalia Arjuna on total platelet count and lipid profile in patients of coronary artery diseaseAdvances in Human Biology.(2019)
  36. ^Varghese A, Savai J, Pandita N, Gaud RIn vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes.Toxicol Rep.(2015)
  37. ^Vijayakumar, TM. et alInhibitory Potency of Selected Therapeutic Bioactive Molecules of Standardized Terminalia arjuna (Roxb.) Extract on CYP3A4 and CYP2D6: Exploring Possible Herb-Drug Interactions.Natural Products Chemistry & Research.(2017)
  38. ^Alice Varghese, Nancy Pandita, R S GaudIn vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna BarkIndian J Pharm Sci.(2014 Mar)
  39. ^Dwivedi STerminalia arjuna Wight & Arn.--a useful drug for cardiovascular disorders.J Ethnopharmacol.(2007 Nov 1)
Examine Database References
  1. Mitral Regurgitation - Dwivedi S, Aggarwal A, Agarwal MP, Rajpal SRole of Terminalia arjuna in ischaemic mitral regurgitationInt J Cardiol.(2005 Apr 28)
  2. Left Ventricular Ejection Fraction - Bharani A, Ganguly A, Bhargava KDSalutary effect of Terminalia Arjuna in patients with severe refractory heart failureInt J Cardiol.(1995 May)
  3. Heart Size - S Dwivedi, R JauhariBeneficial effects of Terminalia arjuna in coronary artery diseaseIndian Heart J.(Sep-Oct 1997)
  4. Anaerobic Capacity - Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MMEffects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adultsInt J Ayurveda Res.(2010 Jul)
  5. Exercise Tolerance - Kaur N, Shafiq N, Negi H, Pandey A, Reddy S, Kaur H, Chadha N, Malhotra STerminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis.Cardiol Res Pract.(2014)